The US Food and Drug Administration (USFDA) has successfully completed an inspection at Anuh Pharma’s facility. The facility was inspected by USFDA from September 16, 2019 to September 20, 2019. At the end of the inspection, no observation (483) was issued.
Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.